Volver a Agenda
Session Chair(s)
Yasuhiro Kanatani
Director, Dept of Health Crisis Management
National Institute of Public Health, Japan
Satoru Hayata, MS
Sobi Japan, Japan
Speaker(s)
Japan Status on Orphan Designation - Past, Present and Future Views
Daiju Okuda
Ministry of Health, Labour and Welfare, Japan
Evaluation and Licensing Division
Current Situation of Investigator Initiated Development of Orphan Drugs - Approaches from Academia
Masanori Fukushima, MD, PHD
Translational Research Center For Medical Innovation, Japan
Director
An Alternative Approach in Development of Orphan Drugs - KOINOBORI Drug Development Support Program -
Taro Inaba
KOINOBORI Associate Inc., Japan
¿Tiene una cuenta?